Open AccessCombination Extended Smoking Cessation Treatment Plus Home Visits for Smokers With Schizophrenia: A Randomized Controlled Trial
Author(s) -
Arthur L. Brody,
Todd Zorick,
Robert Hubert,
Gerhard Hellemann,
Shabnam Balali,
Sarah Kawasaki,
Lizette Garcia,
Ryutaro Enoki,
Paul F. Abraham,
Paulina M. Young,
Charles P. McCreary
Publication year - 2016
Publication title -
nicotine and tobacco research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.338
H-Index - 113
eISSN - 1469-994X
pISSN - 1462-2203
DOI - 10.1093/ntr/ntw190
Subject(s) - medicine , smoking cessation , schizophrenia (object oriented programming) , bupropion , abstinence , randomized controlled trial , psychiatry , population , nicotine , nicotine replacement therapy , adverse effect , environmental health , pathology
The majority of people with schizophrenia have a diagnosis of tobacco dependence during their lifetime. A major obstacle to reducing the burden of cigarette smoking in this population is that these smokers have lower quit rates when undergoing standard treatment compared to smokers with no mental illness. We sought to determine if combination extended treatment (COMB-EXT) and home visits (HV) would lead to improved outcomes in smokers with schizophrenia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom